O'Brien P Q, Thompson G K, Mueller T. "一种的合成方法" [P]. US Patent, US 11408301 B2, 2025-02-22.
发明人马晓峰,胡光,朱建伟. "Method for the Synthesis of [4R-[3(2(S),5(R),4R]]-3-[2-[1-[3-[Bis(phenylmethyl)amino]phenyl]propyl]-5-hydroxy-1,3-dioxo-5-(2-phenylethyl)-6-octynyl]-4-phenyl-2-oxazolidinone" [P]. 中国发明专利, 专利号 CN 109174359 B, 授权公告日 2024-04-19.
参考文献 Literature
Yang F, Sun W, Liu J. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Nat. Prod., 2024, 1550, 8982-9004.
Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Biomed. Chromatogr., 2010, 1410, (5), 1486-1509.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of [4R-[3(2(S),5(R),4R]]-3-[2-[1-[3-[Bis(phenylmethyl)amino]phenyl]propyl]-5-hydroxy-1,3-dioxo-5-(2-phenylethyl)-6-octynyl]-4-phenyl-2-oxazolidinone Using HRMS and NMR". J. Pharm. Biomed. Anal., 2011, 1107, (6), 5706-5724.
Brown R C, Davis S M. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Talanta, 2018, 1020, (10), 7936-7949.